Objective: Adrenal tumors are generally rare in children and can be a part of familial cancer syndrome. This research was conducted to examine the clinical outcomes, histopathological results, and genetic etiologies of adrenal tumors in children and adolescents.
Methods: This research included 31 children and adolescents with adrenal tumors. Data on clinical outcomes and endocrine and radiologic results were retrospectively analyzed. Molecular analysis was conducted in select patients according to their phenotype and family history.
Results: The median age at diagnosis was 7.9 years (range, 0.8−17.8 years) with 5.1 ± 1.8 cm of maximum tumor diameter. Adrenal adenoma (n = 7), carcinoma (n = 5), borderline (n = 2), isolated micronodular adrenocortical disease (n = 2), pheochromocytoma (n = 8), paraganglioma (n = 3), and ganglioneuroma (n = 4) are all pathological diagnoses. The most common presenting symptom was excesses of adrenocortical hormones (n = 15), including virilization and Cushing syndrome. Nonfunctioning adrenocortical tumors were found in a patient with congenital adrenal hyperplasia. Genetic etiologies were identified in TP53 (n = 5), VHL (n = 4), and PRKACA (n = 1). Patients with mutations in TP53 were young (1.5 ± 0.5 years) and had large masses (6.1 ± 2.3 cm).
Conclusions: This study described clinical outcomes and the pathological spectrum in adrenal tumors in children and adolescents. Adrenocortical tumors mostly presented with an excess of the adrenocortical hormone. Patients with genetic defects presented at a young age and large size of tumors, necessitating genetic testing in patients at a young age.